Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03739216 · ClinicalTrials.gov registry record
Registry of Subject Treated With ClariFix
A clinical trial, sponsored by Arrinex.
- Completed
- Registry status
- 354
- Enrollment target
NCT03739216 is a clinical trial that has completed, run by Arrinex. The registered enrollment target is 354 participants.
The verdict
NCT03739216 has completed, sponsored by Arrinex.
- COMPLETED
- Registry status
- 354 participants
- Enrollment target
Study Summary
A multi-center, prospective, non-randomized, observational registry to asses the results of the ClariFix(TM) device when used to ablate unwanted tissue in the nose of subjects with chronic rhinitis.
Interventions
- DEVICE ClariFix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 354 participants |
| Start Date | 2018-06-13 |
| Est. Completion | 2021-06-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03739216
The ClinicalTrials.gov registry entry for NCT03739216 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 354 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Arrinex, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ClariFix is the first listed.
NCT03739216 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03739216 about?
NCT03739216 is a clinical study titled "Registry of Subject Treated With ClariFix". A multi-center, prospective, non-randomized, observational registry to asses the results of the ClariFix(TM) device when used to ablate unwanted tissue in the nose of subjects with chronic rhinitis.
What is the current status of trial NCT03739216?
This trial is currently completed. The enrollment target is 354 participants. The study started on 2018-06-13. Estimated completion is 2021-06-15.
What interventions are being tested in trial NCT03739216?
The interventions under investigation include: ClariFix (DEVICE).
Who is sponsoring clinical trial NCT03739216?
This trial is sponsored by Arrinex, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.